PL3725774T3 - Sposób wytwarzania środka farmaceutycznego - Google Patents
Sposób wytwarzania środka farmaceutycznegoInfo
- Publication number
- PL3725774T3 PL3725774T3 PL19460021T PL19460021T PL3725774T3 PL 3725774 T3 PL3725774 T3 PL 3725774T3 PL 19460021 T PL19460021 T PL 19460021T PL 19460021 T PL19460021 T PL 19460021T PL 3725774 T3 PL3725774 T3 PL 3725774T3
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- pharmaceutical agent
- pharmaceutical
- agent
- Prior art date
Links
- 239000008177 pharmaceutical agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19460021.9A EP3725774B1 (en) | 2019-04-17 | 2019-04-17 | Process for the preparation of a pharmaceutical agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3725774T3 true PL3725774T3 (pl) | 2022-07-11 |
Family
ID=66379857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19460021T PL3725774T3 (pl) | 2019-04-17 | 2019-04-17 | Sposób wytwarzania środka farmaceutycznego |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220033356A1 (pl) |
| EP (1) | EP3725774B1 (pl) |
| ES (1) | ES2908812T3 (pl) |
| PL (1) | PL3725774T3 (pl) |
| WO (1) | WO2020212268A1 (pl) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7790899B2 (en) | 2004-09-27 | 2010-09-07 | Acadia Pharmaceuticals, Inc. | Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| EP3271018B1 (en) | 2015-03-02 | 2020-12-23 | Pliva Hrvatska D.O.O. | Processes and intermediates for the preparation of pimavanserin |
| CZ2015601A3 (cs) * | 2015-09-02 | 2017-03-15 | Zentiva, K.S. | Způsob výroby 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)močoviny a jejích deuterovaných analog neobsahujících dimerické nečistoty |
| CN107641097A (zh) * | 2017-11-15 | 2018-01-30 | 福建省微生物研究所 | 哌马色林的制备方法 |
| ES2906868T3 (es) * | 2019-05-22 | 2022-04-20 | Zakl Farmaceutyczne Polpharma S A | Intermedio farmacéutico para preparar pimavanserina |
-
2019
- 2019-04-17 ES ES19460021T patent/ES2908812T3/es active Active
- 2019-04-17 PL PL19460021T patent/PL3725774T3/pl unknown
- 2019-04-17 EP EP19460021.9A patent/EP3725774B1/en active Active
-
2020
- 2020-04-09 WO PCT/EP2020/060255 patent/WO2020212268A1/en not_active Ceased
-
2021
- 2021-10-18 US US17/503,774 patent/US20220033356A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3725774B1 (en) | 2022-02-23 |
| US20220033356A1 (en) | 2022-02-03 |
| EP3725774A1 (en) | 2020-10-21 |
| ES2908812T3 (es) | 2022-05-04 |
| WO2020212268A1 (en) | 2020-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201911928D0 (en) | Pharmaceutical compounds | |
| IL276917A (en) | A process for the preparation of alubixivet | |
| IL265239A (en) | A process for the production of a solid pharmaceutical preparation | |
| GB201911944D0 (en) | Pharmaceutical compounds | |
| GB2593352B (en) | Process for the preparation of 3alpha-hydroxy-5alpha-pregnan-20-one (brexanolone) | |
| GB201914910D0 (en) | Pharmaceutical compounds | |
| SG11202108238VA (en) | Process for the preparation of methionine | |
| IL289904A (en) | A process for preparing biphenylamines | |
| GB201919336D0 (en) | Pharmaceutical manufacturing process line clearance | |
| GB201915273D0 (en) | Pharmaceutical compounds | |
| PL3765440T3 (pl) | Sposób wytwarzania n-alkilonitratoetylonitroamin | |
| IL275381A (en) | A process for the preparation of Crisborole | |
| GB201915932D0 (en) | Pharmaceutical compounds | |
| IL281254A (en) | A process for the preparation of lanbatinib | |
| IL274757A (en) | A process for preparing drug binding compounds | |
| SG11202103279RA (en) | New amino-pyrimidonyl-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| IL291570A (en) | Pharmaceutical preparations | |
| IL281398A (en) | A process for preparing a pharmaceutical coated solid dosage form | |
| PL3741744T3 (pl) | Farmaceutyczny produkt pośredni do wytwarzania pimawanseryny | |
| IL286054A (en) | A process for the preparation of a modified imidazoquinoline | |
| PL3599256T3 (pl) | Sposób wytwarzania poliorganosiloksanów | |
| IL297715A (en) | pharmaceutical process | |
| PL3725774T3 (pl) | Sposób wytwarzania środka farmaceutycznego | |
| PL3996688T3 (pl) | Preparat farmaceutyczny | |
| HUE055078T2 (hu) | Eljárás cellulóz-karbamát elõállítására |